search
Back to results

Is Periacetabular Osteotomy Superior to Progressive Resistance Training?

Primary Purpose

Hip Dysplasia

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
PAO
Usual care after PAO
PRT
Sponsored by
University of Aarhus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hip Dysplasia focused on measuring Periacetabular Osteotomy, Progressive resistance training, PAO

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Patients aged 18-45 years and diagnosed with hip dysplasia referred from primary care to the Department of Orthopaedic Surgery at one of the two participating hospitals.
  2. Considered eligible for PAO by a surgeon.
  3. Radiographic verified hip dysplasia (CE-angle <25 degrees and AI-angle >10 degrees) and clinical symptoms.
  4. Range of motion: internal rotation >15 degrees, external rotation >15 degrees, hip flexion >110 degrees.
  5. Able to commute to training sessions.

Exclusion Criteria:

  1. OA degree ≥2 on classification of Tönnis'.
  2. CE-angle <10 degrees.
  3. Previous pelvic surgery for hip dysplasia (affected side).
  4. Calvé Legg Perthes or epifysiolysis.
  5. Simultaneous bilateral PAO.
  6. Previous surgery for herniated disc, spondylodesis, arthroplasty of hip, knee or ankle.
  7. Previous surgery of the hip (tenotomy of iliopsoas tendon, z-plastic of the iliotibial tract or hip arthroscopy) in index leg.
  8. Neurological or rheumatoid diseases that affect the hip function.
  9. Inadequacy in written and spoken Danish or Norwegian.
  10. Body Mass Index (BMI) >25 in Aarhus and BMI >30 in Oslo.

Sites / Locations

  • Lisa Urup ReimerRecruiting
  • Oslo University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group 1

Group 2

Arm Description

PAO+usual+PRT

PRT

Outcomes

Primary Outcome Measures

Change in pain related to hip function, between baseline and 12 months follow-up
The pain subscale of the patient reported questionnaire Copenhagen Hip and Groin Outcome Score (HAGOS), were the total score ranges from 0 (worst) to 100 (best).

Secondary Outcome Measures

Change in self-reported hip function
The subscales; Symptoms, Physical function in daily living, Physical function in Sport and Recreation, Participation in Physical Activities and hip and/or groin-related Quality of Life of the patient reported questionnaire Copenhagen Hip and Groin Outcome Score (HAGOS), where the total score ranges from 0 (worst) to 100 (best).
Change in hip function
Single leg hop for distance is a test that measure functional performance requiring both strength, power and balance. The distance from start to landing is measured in cm. and height adjusted by dividing the distance of the hop with the height of the patient.
Change in balance function
The Y balance test require strength, flexibility, neuromuscular control, stability, range of movement, balance and proprioception. These elements are tested and the maximal reach distance is recorded for each direction (anterior, posteromedial and posteroladeral). The composite reach is calculated and normalized to limb length for analysis of the overall performance on the test.
Number of patients with adverse events and serious adverse events after PAO
Adverse events: Haematoma Delayed wound closure Dysaethesia of lateral femoral cutaneous nerve Malpositioning; retroversion or insufficient reorientation. Insufficient reorientation (coverage) - optimal is CE angle 30-40 degrees. AI angle 0-10 degrees. Heterotopic ossifications (Brooker I and II) Urinary tract infections Infection not requiring surgical revision Serious adverse events: Avascular necrosis of the femoral head or acetabulum Nerve palsy Major bleeding (administration of more than 5 blood units intra- and postoperatively) Peroneal and femoral neurapraxia Deep vein thrombosis Pulmonary embolism Stress fracture of ischial bone and posterior column Intraarticular osteotomy Heterotopic ossifications (Brooker III and IV) Infection requiring surgical revision Loss of fixation/loss of reorientation Delayed or non-union of pubic, ischial or iliac bone
Change in usage of painkillers
Usage of painkillers (yes/no), including type of painkillers (Paracetamol, NSAID, Morfin/opiods and/other type of medicine)
Change in self-reported pain
Pain reported by the Visual Analogue Scale (VAS). A scale where pain is marked from 0-100, and 0 is no pain and 100 is worst imaginable pain.
Change in hip awareness
Hip awareness is measured with the Forgotten Joint Score questionnaire (FJS), where each patient completes the 12 questions regarding awareness of their affected hip. Each question is answered with one of the following options; never, almost never, seldom, sometimes and mostly, corresponding to a score of 1-5. The sum of the scores will be converted into a score between 0-100. A high score will indicate lack of awareness and a low score will indicate great awareness of the affected hip.
Change in muscle strength
Muscle strength in hip-abduction, hip-flexion and hip-extension is measured isometrically, with a dynamometer.

Full Information

First Posted
April 29, 2019
Last Updated
April 11, 2023
Sponsor
University of Aarhus
Collaborators
Aarhus University Hospital, VIA University College
search

1. Study Identification

Unique Protocol Identification Number
NCT03941171
Brief Title
Is Periacetabular Osteotomy Superior to Progressive Resistance Training?
Official Title
The Effect of PAO Followed by Progressive Resistance Training Versus Progressive Resistance Training in Patients With Hip Dysplasia. A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2019 (Actual)
Primary Completion Date
January 31, 2025 (Anticipated)
Study Completion Date
January 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
Aarhus University Hospital, VIA University College

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary aim of this study is to examine if Periacetabular Osteotomy (PAO) followed by 4 months of usual care followed by 8 months of progressive resistance training (PRT) is superior to 12 months of a PRT intervention in patients with hip dysplasia eligible for PAO in terms of self-reported pain on the HAGOS questionnaire. Secondary aims are to investigate changes in patient-reported symptoms, physical function in daily living, physical function in sport and recreation, hip and/or groin-related quality of life, generic health status, functional performance, muscle strength, physical activity and adverse events between PAO followed by usual care+PRT compared to PRT only. We hypothesise that in patients with hip dysplasia, PAO followed by usual care+PRT, results in significantly less pain at 12 months follow-up, compared to PRT only.
Detailed Description
Group 1 (PAO+usual+PRT): PAO will be performed as the trans-sartorial approach or the anterior pelvic approach. Patients commence post-operative rehabilitation as usual and follow the rehabilitation program guided by a physiotherapist specialized in hip problems until 4 months after the operation. 4 months postoperative the patients complete usual care and continue with the same PRT intervention program as the PRT group, with 4 months of supervised sessions (see description below). Group 2 (PRT): The PRT group receives 4 months of supervised PRT 2 times per week. A physiotherapist or students will supervise all training sessions the first 4 weeks. The following 4 weeks, 6 out of 8 training sessions are supervised and from week 9-16, half of the training sessions (8 out of 16) are supervised. After these 4 months (16 weeks), patients receive a free membership to a fitness center near their home address and are encouraged to train on their own 2 times per week until 12 months follow-up with one supervised session per month. The PRT program involves 10-min of warm up followed by 50-min of bilateral resistance exercises including sets of loaded squats, hip extension, hip flexion, and hip abduction. The absolute training load will be individually adjusted on a set-by-set basis, using the plus two principle (if the patient is able to perform two or more repetitions than required, the load is increased). Hip related pain levels up to 5 on the VAS is considered acceptable during exercise. The study is a multicentre randomised controlled and assessor blinded trial. Primary endpoint will be 12 months after initiation of surgical/non-surgical treatment. Secondary endpoints will be measured at 4 months after the start of the treatment (surgical/non-surgical). In addition, 5-year and 10-year follow-up with questionnaires is planned.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Dysplasia
Keywords
Periacetabular Osteotomy, Progressive resistance training, PAO

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
Outcomes Assessor
Masking Description
Blinding
Allocation
Randomized
Enrollment
96 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group 1
Arm Type
Experimental
Arm Description
PAO+usual+PRT
Arm Title
Group 2
Arm Type
Active Comparator
Arm Description
PRT
Intervention Type
Procedure
Intervention Name(s)
PAO
Intervention Description
PAO will be performed as the trans-sartorial approach or the anterior pelvic approach.
Intervention Type
Other
Intervention Name(s)
Usual care after PAO
Intervention Description
Patients commence post-operative rehabilitation as usual and follow the rehabilitation program guided by a physiotherapist specialized in hip problems until 4 months after the operation.
Intervention Type
Other
Intervention Name(s)
PRT
Intervention Description
4 months of partly supervised progressive resistance training 2 times per week. After these 4 months (16 weeks), patients receive a free membership to a fitness center near their home address and are encouraged to train on their own 2 times per week until 12 months follow-up with one supervised session per month. The PRT program involves 10-min of warm up followed by 50-min of bilateral resistance exercises including sets of squats, hip extension, hip flexion, and hip abduction.
Primary Outcome Measure Information:
Title
Change in pain related to hip function, between baseline and 12 months follow-up
Description
The pain subscale of the patient reported questionnaire Copenhagen Hip and Groin Outcome Score (HAGOS), were the total score ranges from 0 (worst) to 100 (best).
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Secondary Outcome Measure Information:
Title
Change in self-reported hip function
Description
The subscales; Symptoms, Physical function in daily living, Physical function in Sport and Recreation, Participation in Physical Activities and hip and/or groin-related Quality of Life of the patient reported questionnaire Copenhagen Hip and Groin Outcome Score (HAGOS), where the total score ranges from 0 (worst) to 100 (best).
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Title
Change in hip function
Description
Single leg hop for distance is a test that measure functional performance requiring both strength, power and balance. The distance from start to landing is measured in cm. and height adjusted by dividing the distance of the hop with the height of the patient.
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Title
Change in balance function
Description
The Y balance test require strength, flexibility, neuromuscular control, stability, range of movement, balance and proprioception. These elements are tested and the maximal reach distance is recorded for each direction (anterior, posteromedial and posteroladeral). The composite reach is calculated and normalized to limb length for analysis of the overall performance on the test.
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Title
Number of patients with adverse events and serious adverse events after PAO
Description
Adverse events: Haematoma Delayed wound closure Dysaethesia of lateral femoral cutaneous nerve Malpositioning; retroversion or insufficient reorientation. Insufficient reorientation (coverage) - optimal is CE angle 30-40 degrees. AI angle 0-10 degrees. Heterotopic ossifications (Brooker I and II) Urinary tract infections Infection not requiring surgical revision Serious adverse events: Avascular necrosis of the femoral head or acetabulum Nerve palsy Major bleeding (administration of more than 5 blood units intra- and postoperatively) Peroneal and femoral neurapraxia Deep vein thrombosis Pulmonary embolism Stress fracture of ischial bone and posterior column Intraarticular osteotomy Heterotopic ossifications (Brooker III and IV) Infection requiring surgical revision Loss of fixation/loss of reorientation Delayed or non-union of pubic, ischial or iliac bone
Time Frame
Reported within 12 months after surgery
Title
Change in usage of painkillers
Description
Usage of painkillers (yes/no), including type of painkillers (Paracetamol, NSAID, Morfin/opiods and/other type of medicine)
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Title
Change in self-reported pain
Description
Pain reported by the Visual Analogue Scale (VAS). A scale where pain is marked from 0-100, and 0 is no pain and 100 is worst imaginable pain.
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Title
Change in hip awareness
Description
Hip awareness is measured with the Forgotten Joint Score questionnaire (FJS), where each patient completes the 12 questions regarding awareness of their affected hip. Each question is answered with one of the following options; never, almost never, seldom, sometimes and mostly, corresponding to a score of 1-5. The sum of the scores will be converted into a score between 0-100. A high score will indicate lack of awareness and a low score will indicate great awareness of the affected hip.
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Title
Change in muscle strength
Description
Muscle strength in hip-abduction, hip-flexion and hip-extension is measured isometrically, with a dynamometer.
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up
Other Pre-specified Outcome Measures:
Title
Change in physical activity
Description
Tri-axial accelerometer
Time Frame
Measured at baseline and 12 month follow-up
Title
Change in patient-reported health
Description
Change in patient-reported health will be measured with the EuroQol Group 5-dimension patient-reported questionnaire (EQ-5D-5L), where each dimension has five response levels; ranging from no problems to extreme problems (level 1 to level 5). The scores will be combined, using one level from each dimension, ranging from 11111 (best health) to 55555 (worst health). The instrument also includes a visual analogue scale (VAS) where self-perceived health is scored on a 0 to 100 mm scale representing "the worst health you can imagine" and "the best health you can imagine".
Time Frame
Measured at baseline, 4 month follow-up and 12 month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients aged 18-45 years and diagnosed with hip dysplasia referred from primary care to the Department of Orthopaedic Surgery at one of the two participating hospitals. Considered eligible for PAO by a surgeon. Radiographic verified hip dysplasia (CE-angle <25 degrees and AI-angle >10 degrees) and clinical symptoms. Range of motion: internal rotation >15 degrees, external rotation >15 degrees, hip flexion >110 degrees. Able to commute to training sessions. Exclusion Criteria: OA degree ≥2 on classification of Tönnis'. CE-angle <10 degrees. Previous pelvic surgery for hip dysplasia (affected side). Calvé Legg Perthes or epifysiolysis. Simultaneous bilateral PAO. Previous surgery for herniated disc, spondylodesis, arthroplasty of hip, knee or ankle. Previous surgery of the hip (tenotomy of iliopsoas tendon, z-plastic of the iliotibial tract or hip arthroscopy) in index leg. Neurological or rheumatoid diseases that affect the hip function. Inadequacy in written and spoken Danish or Norwegian. Body Mass Index (BMI) >25 in Aarhus and BMI >30 in Oslo.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lisa CU Reimer, MSc
Phone
+45 26474080
Email
lisareimer@clin.au.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Inger Mechlenburg, DMSc, PhD
Phone
+45 21679062
Email
inger.mechlenburg@clin.au.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lisa CU Reimer, MSc
Organizational Affiliation
Department of Orthopedic Surgery, Aarhus University Hospital, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Inger Mechlenburg, DMSc, PhD
Organizational Affiliation
Department of Clinical Medicine, Aarhus University, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Ulrik Dalgas, MSc, PhD
Organizational Affiliation
Department of Public Health - Sport, Aarhus University, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Stig S Jakobsen, PhD
Organizational Affiliation
Department of Orthopedic Surgery, Aarhus University Hospital, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Kjeld Søballe, DMSc
Organizational Affiliation
Department of Orthopedic Surgery, Aarhus University Hospital, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Julie S Jacobsen, MSc
Organizational Affiliation
Department of Physiotherapy & Research Centre in Health and Welfare Technology, VIA University College, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Jan E Madsen, MD, PhD
Organizational Affiliation
Department of Orthopedic Surgery, Oslo University Hospital, Norway
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Lars Nordsletten, PhD
Organizational Affiliation
Division of Orthopaedic Surgery, Oslo University Hospital, Oslo; Faculty of Medicine, University of Oslo, Norway
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Tone Bere, PT, PhD
Organizational Affiliation
Department of Orthopedics, Oslo University Hospital Ullevaal, Norway
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
May A Risberg, PhD
Organizational Affiliation
Department of Orthopedics, Oslo University Hospital Ullevaal, Norway
Official's Role
Study Director
Facility Information:
Facility Name
Lisa Urup Reimer
City
Århus N
State/Province
Midtjylland
ZIP/Postal Code
8200
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lisa U Reimer, MSc
Phone
26474080
Email
lisareimer@clin.au.dk
First Name & Middle Initial & Last Name & Degree
Inger Mechleburg, DMSc
Phone
+45 2167 9062
Email
Inger.mechlenburg@clin.au.dk
Facility Name
Oslo University Hospital
City
Oslo
ZIP/Postal Code
0450
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tone Bere, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Aarhus University Hospital is responsible for handling all personal data provided by both sites in accordance to the Clinical Trial Agreement and the EU General Data Protection Regulation (GDPR).
IPD Sharing Time Frame
End of study and 5 years ahead
IPD Sharing Access Criteria
Oslo University Hospital agree that information directly related to the protocol and trial, including data, material, Intellectual Property and results generated from the trial shall be the property of Aarhus University Hospital, and shall be treated in strict confidence, and shall not be disclosed to any third party, or use for its benefit or the benefit of any third party, without the prior written consent of Aarhus University Hospital, except for data that is (i) publicly known or available from other sources who are not under a confidentially obligation to the other party; (li) has been made available by the other party without confidentiality obligation; or (iii) is independently developed or otherwise already known by or available to the other party without a confidentiality obligation; or (iv) is already required disclosed by law.
Citations:
PubMed Identifier
31874882
Citation
Reimer LCU, Jakobsen SS, Mortensen L, Dalgas U, Jacobsen JS, Soballe K, Bere T, Madsen JE, Nordsletten L, Risberg MA, Mechlenburg I. Efficacy of periacetabular osteotomy followed by progressive resistance training compared to progressive resistance training as non-surgical treatment in patients with hip dysplasia (PreserveHip) - a protocol for a randomised controlled trial. BMJ Open. 2019 Dec 23;9(12):e032782. doi: 10.1136/bmjopen-2019-032782.
Results Reference
derived

Learn more about this trial

Is Periacetabular Osteotomy Superior to Progressive Resistance Training?

We'll reach out to this number within 24 hrs